In an update to the public last week, the FDA announced that all but one animal drug company have committed to seek withdrawal of approvals for any production uses of affected drug applications and change the remaining therapeutic uses of their products from over-the-counter to use by Veterinary Feed Directive or prescription. These changes stem from the implementation of FDA Guidance #213 that was announced in December of last year. The FDA is pleased with the strong responses received thus far and promises to continue to provide updates to the public. For the official announcement from the FDA, read here.
Industry Commitment For Antibiotic Resistance Strategy
Recent GVL Blog Posts
EDCC Disease Report Update
The Equine Disease Communication Center (EDCC) publishes reports on their Facebook page at the end of each month summarizing disease alerts. We are sharing these reports on the GVL blog, but we encourage you to visit the EDCC website for additional case...
GVL Dairy Industry Expert Patrick Gorden
The GVL® Expert Council was created to better understand our customers’ needs by providing industry knowledge and expertise for product development. We are featuring our Expert Council members on our blog so you can learn more about their fields of research and the...
Certificate Release Due to Hurricane Dorian
GVL will be temporarily releasing Certificates of Veterinary Inspection (CVIs) / health certificates and Equine Infectious Anemia (EIA) / Coggins test certificates to animal owners who need them for evacuations due to Hurricane Dorian. The certificates will be emailed...
